Krystal Biotech, Inc. KRYS Business Segments — Interest and other income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s business segments — interest and other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s business segments — interest and other income, net?
- Krystal Biotech, Inc. (KRYS) reported business segments — interest and other income, net of $7.75M in Q1 2026.
- How has Krystal Biotech, Inc.'s business segments — interest and other income, net changed year-over-year?
- Krystal Biotech, Inc.'s business segments — interest and other income, net increased by 5.6% year-over-year, from $7.35M to $7.75M.
- What does business segments — interest and other income, net mean?
- Net income earned from non-operating sources like interest on cash holdings.
- How do you interpret business segments — interest and other income, net?
- Higher values indicate effective cash management or non-recurring financial gains, while lower values reflect lower interest rates or non-operating losses.
- How does business segments — interest and other income, net compare across companies?
- Commonly reported by companies with significant cash reserves held for future R&D or operational needs.